B6N;129S2(B6J)-Ackr3tm1.1Ics/Ics

Status

Available to order

EMMA IDEM:16057
Citation informationRRID:IMSR_EM:16057 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6N;129S2(B6J)-Ackr3tm1.1Ics/Ics
Alternative nameAckr3tm1.1Ics/Ics
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolAckr3tm1.1Ics
Gene/Transgene symbolAckr3

Information from provider

ProviderMireille Rossel
Provider affiliationINSERM U1198, Laboratoire Mécanismes Moléculaires dans les Démences Neurodégénératives (MMDN)
Genetic informationA FRT-loxP-NeoR-FRT cassette followed by a loxP site was inserted upstream of exon 2 (Ackr3-201, GCRm39) and a second loxP site was inserted downstream exon 2; flp-mediated recombination removed the selection cassette and left exons 2 floxed.
Phenotypic informationHomozygous:
N/A

Heterozygous:
N/A
Breeding historyLine backcrossed 2 times in C57BL/6NTac. Current background: C57BL/6J 6.25%, 129/SvPas 25%, C57BL/6N 68.75%
References
  • CXCR7 Receptor Controls the Maintenance of Subpial Positioning of Cajal-Retzius Cells.;Trousse Françoise, Poluch Sylvie, Pierani Alessandra, Dutriaux Annie, Bock Hans H, Nagasawa Takashi, Verdier Jean-Michel, Rossel Mireille, ;2015;Cerebral cortex (New York, N.Y. : 1991);25;3446-57; 25085881
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased grip strength / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • increased mean corpuscular hemoglobin concentration / IMPC
  • decreased total retina thickness / IMPC
  • tremors / IMPC
MGI phenotypes (gene matching)
  • abnormal heart morphology / MGI
  • overriding aortic valve / MGI
  • enlarged heart / MGI
  • heart hyperplasia / MGI
  • abnormal interventricular septum morphology / MGI
  • abnormal atrioventricular cushion morphology / MGI
  • abnormal cardiovascular system physiology / MGI
  • cyanosis / MGI
  • abnormal blood vessel morphology / MGI
  • abnormal atrial thrombosis / MGI
  • lung inflammation / MGI
  • hemorrhage / MGI
  • respiratory distress / MGI
  • premature death / MGI
  • abnormal semilunar valve morphology / MGI
  • abnormal aortic valve morphology / MGI
  • abnormal pulmonary valve morphology / MGI
  • dilated heart right ventricle / MGI
  • dilated heart atrium / MGI
  • cardiac fibrosis / MGI
  • nervous system phenotype / MGI
  • myocardial fiber degeneration / MGI
  • digestive/alimentary phenotype / MGI
  • immune system phenotype / MGI
  • hematopoietic system phenotype / MGI
  • pulmonary fibrosis / MGI
  • calcified aortic valve / MGI
  • aortic valve stenosis / MGI
  • abnormal cardiac outflow tract development / MGI
  • pulmonary valve stenosis / MGI
  • decreased marginal zone B cell number / MGI
  • decreased survivor rate / MGI
  • ventricular septal defect / MGI
  • atrial septal defect / MGI
  • perimembraneous ventricular septal defect / MGI
  • abnormal heart and great artery attachment / MGI
  • thick aortic valve / MGI
  • thick pulmonary valve / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • neonatal lethality, complete penetrance / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • perinatal lethality, complete penetrance / MGI
  • perinatal lethality, incomplete penetrance / MGI

Literature references

  • CXCR7 Receptor Controls the Maintenance of Subpial Positioning of Cajal-Retzius Cells.;Trousse Françoise, Poluch Sylvie, Pierani Alessandra, Dutriaux Annie, Bock Hans H, Nagasawa Takashi, Verdier Jean-Michel, Rossel Mireille, ;2015;Cerebral cortex (New York, N.Y. : 1991);25;3446-57; 25085881

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).